1. "2018"
Formats
  1. Journal Article (3011)
  2. Meeting Abstract (1948)
  3. Book Section (206)
  4. Conference Paper (38)
  5. Book Whole (11)
  6. Editorial (4)
  7. Review (4)
  8. Miscellaneous (2)
  9. Correspondence (1)
Groups
  1. Department of Medicine (2296)
  2. Solid Tumor Oncology Division (1378)
  3. GSK Faculty (1136)
  4. Sloan Kettering Institute Postdocs (1044)
  5. Surgery (870)
  6. Center for Hematologic Malignancies (863)

More Groups

People
  1. Sergio Giralt (87)
  2. Matthew Hellmann (78)
  3. Jedd Wolchok (74)
  4. Marc Ladanyi (74)
  5. Robert Motzer (71)
  6. Nancy Lee (64)

More People

Years
  1. 2018 (5225)
Publications
  1. Journal of Clinical Oncology (562)
  2. Blood (249)
  3. Cancer Research (183)
  4. Annals of Oncology (140)
  5. International Journal of Radiation Oncology, Biology, Physics (137)
  6. Modern Pathology (127)

More Publications

Publishers
  1. Elsevier Inc. (691)
  2. American Society of Clinical Oncology (605)
  3. Springer (410)
  4. American Association for Cancer Research (299)
  5. Oxford University Press (291)
  6. American Society of Hematology (273)

More Publishers

Results (5225)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • MET exon 14-altered lung cancers: Central nervous system (CNS) metastases and patterns of CNS progression on MET inhibition
    Meeting Abstract

    Offin, M.; Dienstag, J.; Wilkins, O.; Sabari, J.; Ni, A.; Feldman, D.; Van Voorthuysen, M.; Suzawa, K.; Yu, H.; Riely, G.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Utility of cfDNA testing for acquired resistance: The Memorial Sloan Kettering experience with plasma EGFR T790M clinical testing
    Meeting Abstract

    Offin, M.; Myers, M.; Josyula, S.; Shen, R.; Borsu, L.; Tsui, D.; Riely, G.; Rudin, C.; Yu, H.; Li, B.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Correlation of the Lung Immune Prognostic Index (LIPI) and PDL1 status with outcomes for immune checkpoint inhibitors in advanced NSCLC patients
    Meeting Abstract

    Mezquita, L.; Park, W.; Arbour, K.; Auclin, E.; Hendriks, L.; Planchard, D.; Saravia, D.; Ponce Aix, S.; Nadal, E.; Audigier-Valette, C.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Long-term outcomes with first-line nivolumab plus ipilimumab in advanced NSCLC: 3-year follow-up from CheckMate 012
    Meeting Abstract

    Antonia, S.; Gettinger, S.; Borghaei, H.; Goldman, J. W.; Brahmer, J.; Ready, N.; Gerber, D.; Chow, L.; Juergens, R.; Laurie, S.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • CNS activity of ramucirumab in combination with osimertinib in patients with advanced T790M-positive EGFR-mutant NSCLC
    Meeting Abstract

    Paz-Ares, L.; Planchard, D.; Yang, J. C.; Lee, K.; Garrido, P.; Park, K.; Kim, J.; Lee, D. H.; Mao, H.; Chao, B.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Impact of tumor spread through air spaces (STAS) in lung neuroendocrine tumors (NETs)
    Meeting Abstract

    Aly, R.; Eguchi, T.; Kadota, K.; Rekhtman, N.; Tan, K. S.; Adusumilli, P.; Travis, W.
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • PARP inhibitor radiosensitization of small cell lung cancer differs by PARP trapping potency
    Meeting Abstract

    Lok, B.; Laird, J.; Ma, J.; De Stanchina, E.; Poirier, J.; Rudin, C.
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Concurrent mutations in STK11 and KEAP1 is associated with resistance to PD-(L)1 blockade in patients with NSCLC despite high TMB
    Meeting Abstract

    Arbour, K.; Shen, R.; Plodkowski, A.; Rizvi, H.; Ni, A.; Long, N.; Halpenny, D.; Sanchez-Vega, F.; Rudin, C.; Riely, G.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • An ex-vivo patient-derived, immunocompetent (PDI) culture system to evaluate immunotherapeutic agents' anti-tumor efficacy
    Meeting Abstract

    Tano, Z.; Kiesgen, S.; Chintala, N.; Dozier, J.; Messinger, J.; Tan, K. S.; Adusumilli, P.
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Comparative efficacy of T-cell intrinsic versus extrinsic PD-1 blockade to overcome PD-L1+ tumor-mediated exhaustion
    Meeting Abstract

    Dozier, J.; Chen, N.; Saini, J.; Chintala, N.; Adusumilli, P.
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save